Cochrane · intervention · CD007975

Topical treatments for HIV‐related oral ulcers

Kuteyi, T, Okwundu, CI · Cochrane Database of Systematic Reviews · 2012 · Cochrane Library

HIV/AIDSOral HealthOther oral health2 versionsAMSTAR 2: not assessed
Full textEvery question was extracted from the full review (methods and results), not only its Summary of Findings table.
Questions
20
current version
GRADE rated
0
No studies
20
Included studies
0
as reported
No studies 20 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Review question

ElementPlanned (methods)Found (results)
PopulationHIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcersInsufficient data
InterventionTopical corticosteroids; Topical thalidomide; Antiseptic mouth washes such as chlorhexidine; Any HAART regimen + any topical treatmentInsufficient data
ComparisonAnother topical agent; Placebo; HAART regimen aloneInsufficient data
OutcomesHealing of ulceration; Pain relief; Duration to heal oral ulcerations after initiation of treatment; Incidence and recurrence after healing of ulcers; Adverse effects of long‐term use of available topical agentsInsufficient data
Study designsRandomised controlled trialsInsufficient data
TimingNot specifiedInsufficient data

Search date: 2011-05. Databases: PUBMED; EMBASE; The Cochrane Central Register of Controlled Trials (CENTRAL); AEGIS; ClinicalTrials.gov

Questions and results

Current version only

Topical corticosteroids vs Another topical agent or placebo

Population: HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers
CD007975.PUB2 (current) · 5 questions
OutcomeEffectEvidenceStatus / GRADE
Pain relief
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Adverse effects of long‐term use of available topical agents
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Duration to heal oral ulcerations after initiation of treatment
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Healing of ulceration
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Incidence and recurrence after healing of ulcers
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies

Topical thalidomide vs Another topical agent or placebo

Population: HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers
CD007975.PUB2 (current) · 5 questions
OutcomeEffectEvidenceStatus / GRADE
Incidence and recurrence after healing of ulcers
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Pain relief
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Adverse effects of long‐term use of available topical agents
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Healing of ulceration
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Duration to heal oral ulcerations after initiation of treatment
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies

Antiseptic mouthwash (e.g. chlorhexidine) vs Another topical agent or placebo

Population: HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers
CD007975.PUB2 (current) · 5 questions
OutcomeEffectEvidenceStatus / GRADE
Pain relief
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Incidence and recurrence after healing of ulcers
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Duration to heal oral ulcerations after initiation of treatment
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Healing of ulceration
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Adverse effects of long‐term use of available topical agents
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies

HAART regimen + topical treatment vs HAART regimen alone

Population: HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers
CD007975.PUB2 (current) · 5 questions
OutcomeEffectEvidenceStatus / GRADE
Adverse effects of long‐term use of available topical agents
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Duration to heal oral ulcerations after initiation of treatment
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Healing of ulceration
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Pain relief
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies
Incidence and recurrence after healing of ulcers
No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6…0 studiesNo studies

Topical corticosteroids vs Another topical agent or placebo

Population: HIV‐positive individuals of at least 15 years of age with one or more painful intraoral ulcers
CD007975 · 5 questions
OutcomeEffectEvidenceStatus / GRADE
Duration to heal oral ulcerations after initiation of treatment
no estimate extracted0 studiesNo studies
Incidence and recurrence after healing of ulcers
no estimate extracted0 studiesNo studies
Adverse effects of long‐term use of available topical agents
no estimate extracted0 studiesNo studies
Healing of ulceration
no estimate extracted0 studiesNo studies
Pain relief
no estimate extracted0 studiesNo studies

Topical thalidomide vs Another topical agent or placebo

Population: HIV‐positive individuals of at least 15 years of age with one or more painful intraoral ulcers
CD007975 · 5 questions
OutcomeEffectEvidenceStatus / GRADE
Duration to heal oral ulcerations after initiation of treatment
no estimate extracted0 studiesNo studies
Pain relief
no estimate extracted0 studiesNo studies
Incidence and recurrence after healing of ulcers
no estimate extracted0 studiesNo studies
Adverse effects of long‐term use of available topical agents
no estimate extracted0 studiesNo studies
Healing of ulceration
no estimate extracted0 studiesNo studies

Antiseptic mouthwash (e.g. chlorhexidine) vs Another topical agent or placebo

Population: HIV‐positive individuals of at least 15 years of age with one or more painful intraoral ulcers
CD007975 · 5 questions
OutcomeEffectEvidenceStatus / GRADE
Duration to heal oral ulcerations after initiation of treatment
no estimate extracted0 studiesNo studies
Incidence and recurrence after healing of ulcers
no estimate extracted0 studiesNo studies
Pain relief
no estimate extracted0 studiesNo studies
Adverse effects of long‐term use of available topical agents
no estimate extracted0 studiesNo studies
Healing of ulceration
no estimate extracted0 studiesNo studies

HAART regimen + topical treatment vs HAART regimen alone

Population: HIV‐positive individuals of at least 15 years of age with one or more painful intraoral ulcers
CD007975 · 5 questions
OutcomeEffectEvidenceStatus / GRADE
Incidence and recurrence after healing of ulcers
no estimate extracted0 studiesNo studies
Healing of ulceration
no estimate extracted0 studiesNo studies
Pain relief
no estimate extracted0 studiesNo studies
Adverse effects of long‐term use of available topical agents
no estimate extracted0 studiesNo studies
Duration to heal oral ulcerations after initiation of treatment
no estimate extracted0 studiesNo studies